Products

Products

Products

Kadmon Pharmaceuticals is our wholly owned, fully integrated commercial operation. Kadmon Pharmaceuticals will support the future commercialization of our clinical product candidates once approved.

Kadmon currently markets and promotes CLOVIQUE, a product developed in-house at Kadmon which is a trientine hydrochloride. For more information, see clovique.com.  

CLOVIQUE™ (Trientine Hydrochloride Capsules, USP) Blister Pack

trientine hydrochloride capsules, USP

CLOVIQUE™ (Trientine Hydrochloride Capsules, USP) Blister Pack

Disclaimer

Medical Information
For product inquiries or to report an adverse event or product quality complaint for a Kadmon marketed product, please call 1.877.377.7862. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1.800.FDA.1088.

Consumer Product Safety Improvement Act (CPSIA) Certification
In accordance with the CPSIA of 2008, Kadmon certifies that our product’s child-resistant packaging comply with the standards established under the Poison Prevention Packaging Act of 1970 as amended. To receive a copy of a CPSIA certificate for a Kadmon product, please contact Medical Information at 1.877.377.7862 or .